Nov. 27, 2002 -- Diagnoses of autism are increasing at
an alarming rate, and the disorder could cause serious strains on social
services. Those were the conclusions of researchers, physicians, and
patient advocates who attended a meeting of the National Institute of
Health's Interagency Autism Coordinating Committee.
Autistic patients have trouble with verbal and nonverbal
development, usually with delays in language development that can
sometimes be quite severe. They also have difficulty with social
interactions and tend to stick to limited and repetitive patterns of
behavior.
Diagnoses are on the upswing. California, for example,
has seen a dramatic increase in the number of autistic patients that
participate in its social services programs. "Autistic patients have
jumped from 3% to 40% in California's developmental services program,"
says Rick Rollens, of the University of California at Davis-based
M.I.N.D. Institute, which is dedicated to autism research and care.
It is not clear whether such increases represent a
burgeoning epidemic or if mental health professionals are simply more
aware of its existence and therefore diagnosing it more frequently.
Either way, it seems likely to put a strain on schools and social
services organizations in the coming years.
The disorder varies widely in its symptoms and severity,
with some patients experiencing relatively mild symptoms. Others may
have severe impairment of social interactions and language, leaving them
virtually speechless.
Many of them remain undiagnosed well into adulthood,
according to Bernice Polinsky, of AHA/AS/PDD (Advocates for Individuals
with High Functioning Autism, Asperger's Syndrome and Other Pervasive
Development Disorders). "They're falling through the cracks. They're
dropping out of college, they're not getting jobs."
Public health officials would like to develop effective
screens for autism, because early intervention can improve a patient's
quality of life. "[Social interaction] is impaired, but it's not
absent," says Helen Tager-Flusberg, PhD, of Boston University's
department of psychology.
Part of the problem is that autism is poorly understood.
It appears to have a genetic component, but exposure to several
chemicals also increase risk. Patricia Rodier, MD, professor of
obstetrics and gynecology at the University of Rochester, presented the
results of a study of these factors. In all cases, the damage appeared
to occur in the initial stages of pregnancy, in the parts of the brain
that form earliest.
If the damage does indeed occur so early in development,
it may explain why there are no medications to directly treat the
condition. There are plenty of drugs available to treat some of its
symptoms, but none that can achieve a cure.
That means that autistic patients are likely to stay on
medications over long periods of time, raising concerns about side
effects that range from mild to serious. One of the more effective
drugs, Risperdal, is among the most effective for controlling tantrums,
and aggressive and self-injury behaviors that can be associated with
autism.
In a study published in The New England Journal of
Medicine in August, a team led by Benedetto Vitiello, MD, of the
National Institute of Mental Health, reported that the drug was
effective and well tolerated by autistic patients. Since then, the team
has taken some of the patients off of the drug and put them on placebo
to see if the beneficial effects continued. Disappointingly, two-thirds
of the patients relapsed. "But the interesting part is that one-third
did OK without medication," Vitiello tells WebMD. He hopes that future
studies will reveal the reason for the difference.
Those and other studies should begin to unravel the
mystery that is autism. The better we understand it, the better-equipped
physicians, teachers, and social workers will be to manage and soften
its impact.
SOURCES: Rick Rollens, University of
California at Davis-based M.I.N.D. Institute • Bernice Polinsky, AHA/AS/PDD
(Advocates for Individuals with High Functioning Autism, Asperger's
Syndrome and Other Pervasive Development Disorders) • Helen
Tager-Flusberg, PhD, department of psychology,Boston University •
Patricia Rodier, MD, professor of obstetrics and gynecology, University
of Rochester • Benedetto Vitiello, MD, National Institute of Mental
Health.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.